Skip to main content
Top
Published in: BMC Infectious Diseases 1/2023

Open Access 01-12-2023 | Echinococcosis | Case Report

Kidney invasion occurred 2 years following liver transplantation for hepatic alveolar echinococcosis: a case report

Authors: Qirui Hu, Simin Chen, Yichen Fan, Qian Lu, Manjun Deng, Haining Fan

Published in: BMC Infectious Diseases | Issue 1/2023

Login to get access

Abstract

Background

The organ most commonly invaded in echinococcosis is the liver; the lungs, brain, kidneys, heart, and spleen are rarely invaded, and multi-organ involvement in echinococcosis is even rarer. No studies have reported renal invasion after liver transplantation for hepatic alveolar echinococcosis.

Case presentation

We report here a case of renal invasion 2 years after allogeneic liver transplantation in a 53-year-old female patient with hepatic alveolar echinococcosis combined with lung metastases. At the time of the first consultation, the lesion had been found to involve the second hepatic hilum combined with lung metastases, but the patient requested conservative treatment, and the lesion was not controlled by taking albendazole for 3 years. After discussion in the treatment group, it was decided to use allogeneic liver transplantation and lung segmental resection for surgical treatment, after which the patient was put on long-term oral immunosuppression. She was hospitalized 2 years later for low back pain and diagnosed with renal alveolar echinococcosis. Due to significant compression and left-sided renal insufficiency, the final option was to remove the diseased kidney. It is worth mentioning that signs of unexplained urinary tract infection were present throughout the course of treatment.

Conclusion

This study suggests that extra attention should be paid to the presence of cryptogenic lesions in patients with hepatic alveolar echinococcosis who already have definite metastatic lesions. Immunosuppressive drugs after liver transplantation in patients with hepatic echinococcosis may cause occult lesions to develop into active ones. In clinical practice, particular attention should be paid to patients with hepatic alveolar echinococcosis with long-term concomitant signs of unexplained urinary tract infections, which may be a precursor clinical feature of cryptogenic renal alveolar echinococcosis.
Literature
1.
go back to reference Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W. Echinococcosis: advances in the 21st century. CLIN MICROBIOL REV. 2019;32. Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W. Echinococcosis: advances in the 21st century. CLIN MICROBIOL REV. 2019;32.
2.
go back to reference McManus DP, Gray DJ, Zhang W, Yang Y. Diagnosis, treatment, and management of echinococcosis. BMJ-BRIT MED J. 2012;344:e3866.CrossRef McManus DP, Gray DJ, Zhang W, Yang Y. Diagnosis, treatment, and management of echinococcosis. BMJ-BRIT MED J. 2012;344:e3866.CrossRef
3.
go back to reference Sulima M, Wołyniec W, Oładakowska-Jedynak U, Patkowski W, Wasielak N, Witczak-Malinowska K. Liver transplantation for incurable alveolar echinococcosis: an analysis of patients hospitalized in department of tropical and parasitic Diseases in Gdynia. TRANSPL P. 2016;48:1708–12.CrossRef Sulima M, Wołyniec W, Oładakowska-Jedynak U, Patkowski W, Wasielak N, Witczak-Malinowska K. Liver transplantation for incurable alveolar echinococcosis: an analysis of patients hospitalized in department of tropical and parasitic Diseases in Gdynia. TRANSPL P. 2016;48:1708–12.CrossRef
4.
go back to reference Wang Z, Jiang T, Aji T, Wen H. Massive sympathetic nerve infiltration in advanced hepatic alveolar echinococcosis: a case report and review of the literature. BMC INFECT DIS. 2022;22:489.CrossRefPubMedPubMedCentral Wang Z, Jiang T, Aji T, Wen H. Massive sympathetic nerve infiltration in advanced hepatic alveolar echinococcosis: a case report and review of the literature. BMC INFECT DIS. 2022;22:489.CrossRefPubMedPubMedCentral
5.
go back to reference Aji T, Dong JH, Shao YM, Zhao JM, Li T, Tuxun T. Ex vivo liver resection and autotransplantation as alternative to allotransplantation for end-stage hepatic alveolar echinococcosis. J HEPATOL. 2018;69:1037–46.CrossRefPubMed Aji T, Dong JH, Shao YM, Zhao JM, Li T, Tuxun T. Ex vivo liver resection and autotransplantation as alternative to allotransplantation for end-stage hepatic alveolar echinococcosis. J HEPATOL. 2018;69:1037–46.CrossRefPubMed
6.
go back to reference Wen H, Dong JH, Zhang JH, Duan WD, Zhao JM, Liang YR. Ex vivo liver resection and autotransplantation for end-stage alveolar echinococcosis: a case series. AM J TRANSPLANT. 2016;16:615–24.CrossRefPubMed Wen H, Dong JH, Zhang JH, Duan WD, Zhao JM, Liang YR. Ex vivo liver resection and autotransplantation for end-stage alveolar echinococcosis: a case series. AM J TRANSPLANT. 2016;16:615–24.CrossRefPubMed
7.
go back to reference Bresson-Hadni S, Koch S, Miguet JP, Gillet M, Mantion GA, Heyd B. Indications and results of liver transplantation for echinococcus alveolar Infection: an overview. LANGENBECK ARCH SURG. 2003;388:231–8.CrossRef Bresson-Hadni S, Koch S, Miguet JP, Gillet M, Mantion GA, Heyd B. Indications and results of liver transplantation for echinococcus alveolar Infection: an overview. LANGENBECK ARCH SURG. 2003;388:231–8.CrossRef
8.
go back to reference Aliakbarian M, Tohidinezhad F, Eslami S, Akhavan-Rezayat K. Liver transplantation for hepatic alveolar echinococcosis: literature review and three new cases. INFECT DIS-NOR. 2018;50:452–9.CrossRef Aliakbarian M, Tohidinezhad F, Eslami S, Akhavan-Rezayat K. Liver transplantation for hepatic alveolar echinococcosis: literature review and three new cases. INFECT DIS-NOR. 2018;50:452–9.CrossRef
9.
go back to reference Kern P, Menezes DSA, Akhan O, Müllhaupt B, Vizcaychipi KA, Budke C. The echinococcoses: diagnosis, clinical management and burden of Disease. ADV PARASIT. 2017;96:259–369.CrossRef Kern P, Menezes DSA, Akhan O, Müllhaupt B, Vizcaychipi KA, Budke C. The echinococcoses: diagnosis, clinical management and burden of Disease. ADV PARASIT. 2017;96:259–369.CrossRef
10.
go back to reference Bentani N, Basraoui D, Wakrim B, Hiroual MR, Cherif IGN, Dahami Z. [renal hydatid cyst: radiologic features and therapy]. PROG UROL. 2012;22:999–1003.CrossRefPubMed Bentani N, Basraoui D, Wakrim B, Hiroual MR, Cherif IGN, Dahami Z. [renal hydatid cyst: radiologic features and therapy]. PROG UROL. 2012;22:999–1003.CrossRefPubMed
11.
go back to reference Yousofi DH, Jafari R. Renal echinococcosis; the parasite, host immune response, diagnosis and management. J INFECT DEV COUNTR. 2020;14:420–7.CrossRef Yousofi DH, Jafari R. Renal echinococcosis; the parasite, host immune response, diagnosis and management. J INFECT DEV COUNTR. 2020;14:420–7.CrossRef
Metadata
Title
Kidney invasion occurred 2 years following liver transplantation for hepatic alveolar echinococcosis: a case report
Authors
Qirui Hu
Simin Chen
Yichen Fan
Qian Lu
Manjun Deng
Haining Fan
Publication date
01-12-2023

Other articles of this Issue 1/2023

BMC Infectious Diseases 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine